Arcutis Biotherapeutics (ARQT) Interest Coverage Ratio (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Interest Coverage Ratio of 2.07 for Q1 2026, up 74.74% year-over-year from 1.18 in Q1 2025, and down 128.54% quarter-over-quarter from 7.24 in Q4 2025.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 2.07 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 74.74% year-over-year to 2.07; the TTM figure through Mar 2026 stood at 0.25 (up 105.09% YoY), while the FY2025 annual figure was 0.05, up 90.45% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.07, down from 7.24 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 7.24 in Q4 2025, with the low at 34.07 in Q1 2022.
- The 5-year median for Interest Coverage Ratio is 6.68 (2024), against an average of 9.23.
- Peak annual rise in Interest Coverage Ratio reached 850.74% in 2025, while the deepest fall reached 93.92% in 2025.
- Arcutis Biotherapeutics' Interest Coverage Ratio stood at 17.55 in 2022, then jumped by 55.09% to 7.88 in 2023, then jumped by 87.76% to 0.96 in 2024, then jumped by 850.74% to 7.24 in 2025, then plunged by 128.54% to 2.07 in 2026.
- Business Quant data shows ARQT's Interest Coverage Ratio at 2.07 in Q1 2026, 7.24 in Q4 2025, and 2.75 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Arcutis Biotherapeutics | 3.12 Bn | 2.88 Bn | 118.92 Mn | 4.82 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.82 |
| Mar 31, 2026 | -2.08 |
| Dec 31, 2025 | 6.13 |
| Sep 30, 2025 | 2.78 |
| Jun 30, 2025 | -4.82 |
| Mar 31, 2025 | -8.23 |
| Dec 31, 2024 | -1.37 |
| Sep 30, 2024 | -5.87 |
| Jun 30, 2024 | -6.69 |
| Mar 31, 2024 | -4.23 |
| Dec 31, 2023 | -7.88 |
| Sep 30, 2023 | -4.88 |
| Jun 30, 2023 | -9.08 |
| Mar 31, 2023 | -10.83 |
| Dec 31, 2022 | -9.90 |
| Sep 30, 2022 | -21.38 |
| Jun 30, 2022 | -32.91 |
| Mar 31, 2022 | -34.07 |